How much profit has Uni-Bio Science Group made this year?
Uni-Bio Science Group has made 70.88 M HKD this year.
Uni-Bio Science Group Net Income 2024
Uni-Bio Science Group Net Income
70.88 M HKD
Ticker
690.HK
ISIN
KYG9198H1406
In 2024, Uni-Bio Science Group's profit amounted to 70.88 M HKD, a 84.04% increase from the 38.51 M HKD profit recorded in the previous year.
The Uni-Bio Science Group Net Income history
| YEAR | NET INCOME (undefined HKD) |
|---|---|
| 2023 | 70.88 |
| 2022 | 38.51 |
| 2021 | -19.59 |
| 2020 | -71.32 |
| 2019 | 2.46 |
| 2018 | -138.57 |
| 2017 | -279.31 |
| 2016 | -55.73 |
| 2015 | -59.8 |
| 2014 | -42.43 |
| 2013 | -366.1 |
| 2012 | -69.3 |
| 2011 | -102.9 |
| 2010 | -185.2 |
| 2009 | -454.7 |
| 2008 | -508.3 |
| 2007 | 198.4 |
| 2006 | 60.3 |
| 2005 | -42.4 |
| 2004 | -0.1 |
Uni-Bio Science Group Revenue, EBIT, Net Income KYG9198H1406 ·
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Uni-Bio Science Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Uni-Bio Science Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Uni-Bio Science Group’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Uni-Bio Science Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Uni-Bio Science Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Uni-Bio Science Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Uni-Bio Science Group’s growth potential.
Uni-Bio Science Group Revenue, EBIT and net profit per share
| Date | Uni-Bio Science Group Revenue | Uni-Bio Science Group EBIT | Uni-Bio Science Group Net Income |
|---|---|---|---|
| 2023 | 484.72 M HKD | 75.94 M HKD | 70.88 M HKD |
| 2022 | 440.32 M HKD | 45.21 M HKD | 38.51 M HKD |
| 2021 | 353.41 M HKD | -2.12 M HKD | -19.59 M HKD |
| 2020 | 208.78 M HKD | -38.87 M HKD | -71.32 M HKD |
| 2019 | 209.45 M HKD | -59.13 M HKD | 2.46 M HKD |
| 2018 | 135.26 M HKD | -118.64 M HKD | -138.57 M HKD |
| 2017 | 156.48 M HKD | -79.81 M HKD | -279.31 M HKD |
| 2016 | 146.49 M HKD | -55.73 M HKD | -55.73 M HKD |
| 2015 | 123.36 M HKD | -57.71 M HKD | -59.8 M HKD |
| 2014 | 91.79 M HKD | -45.4 M HKD | -42.43 M HKD |
| 2013 | 102.6 M HKD | -110.5 M HKD | -366.1 M HKD |
| 2012 | 83.3 M HKD | -62.2 M HKD | -69.3 M HKD |
| 2011 | 57 M HKD | -77.3 M HKD | -102.9 M HKD |
| 2010 | 76.8 M HKD | -72.3 M HKD | -185.2 M HKD |
| 2009 | 148.3 M HKD | -144.4 M HKD | -454.7 M HKD |
| 2008 | 526.3 M HKD | -238.2 M HKD | -508.3 M HKD |
| 2007 | 869.9 M HKD | 335.6 M HKD | 198.4 M HKD |
| 2006 | 340.9 M HKD | 130.1 M HKD | 60.3 M HKD |
| 2005 | 94.9 M HKD | -6.3 M HKD | -42.4 M HKD |
| 2004 | 134.3 M HKD | 5.1 M HKD | -100,000 HKD |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 134.3 M HKD | 5.1 M HKD | -100,000 HKD |
| 2005 | 94.9 M HKD | -6.3 M HKD | -42.4 M HKD |
| 2006 | 340.9 M HKD | 130.1 M HKD | 60.3 M HKD |
| 2007 | 869.9 M HKD | 335.6 M HKD | 198.4 M HKD |
| 2008 | 526.3 M HKD | -238.2 M HKD | -508.3 M HKD |
| 2009 | 148.3 M HKD | -144.4 M HKD | -454.7 M HKD |
| 2010 | 76.8 M HKD | -72.3 M HKD | -185.2 M HKD |
| 2011 | 57 M HKD | -77.3 M HKD | -102.9 M HKD |
| 2012 | 83.3 M HKD | -62.2 M HKD | -69.3 M HKD |
| 2013 | 102.6 M HKD | -110.5 M HKD | -366.1 M HKD |
| 2014 | 91.79 M HKD | -45.4 M HKD | -42.43 M HKD |
| 2015 | 123.36 M HKD | -57.71 M HKD | -59.8 M HKD |
| 2016 | 146.49 M HKD | -55.73 M HKD | -55.73 M HKD |
| 2017 | 156.48 M HKD | -79.81 M HKD | -279.31 M HKD |
| 2018 | 135.26 M HKD | -118.64 M HKD | -138.57 M HKD |
| 2019 | 209.45 M HKD | -59.13 M HKD | 2.46 M HKD |
| 2020 | 208.78 M HKD | -38.87 M HKD | -71.32 M HKD |
| 2021 | 353.41 M HKD | -2.12 M HKD | -19.59 M HKD |
| 2022 | 440.32 M HKD | 45.21 M HKD | 38.51 M HKD |
| 2023 | 484.72 M HKD | 75.94 M HKD | 70.88 M HKD |
Uni-Bio Science Group stock margins KYG9198H1406 ·
The Uni-Bio Science Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Uni-Bio Science Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Uni-Bio Science Group.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Uni-Bio Science Group's sales revenue. A higher gross margin percentage indicates that the Uni-Bio Science Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Uni-Bio Science Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Uni-Bio Science Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Uni-Bio Science Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Uni-Bio Science Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Uni-Bio Science Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Uni-Bio Science Group Margin History
| Uni-Bio Science Group Gross margin | Uni-Bio Science Group Profit margin | Uni-Bio Science Group EBIT margin | Uni-Bio Science Group Profit margin |
|---|---|---|---|
| 2023 | 81.04 % | 15.67 % | 14.62 % |
| 2022 | 76.06 % | 10.27 % | 8.75 % |
| 2021 | 78.38 % | -0.6 % | -5.54 % |
| 2020 | 86.74 % | -18.62 % | -34.16 % |
| 2019 | 86.66 % | -28.23 % | 1.17 % |
| 2018 | 86.95 % | -87.72 % | -102.45 % |
| 2017 | 85.4 % | -51 % | -178.5 % |
| 2016 | 84.56 % | -38.04 % | -38.04 % |
| 2015 | 83.29 % | -46.78 % | -48.47 % |
| 2014 | 83.52 % | -49.45 % | -46.23 % |
| 2013 | 80.02 % | -107.7 % | -356.82 % |
| 2012 | 79.59 % | -74.67 % | -83.19 % |
| 2011 | 67.19 % | -135.61 % | -180.53 % |
| 2010 | 62.11 % | -94.14 % | -241.15 % |
| 2009 | 52.06 % | -97.37 % | -306.61 % |
| 2008 | 61.81 % | -45.26 % | -96.58 % |
| 2007 | 61.81 % | 38.58 % | 22.81 % |
| 2006 | 54.33 % | 38.16 % | 17.69 % |
| 2005 | 17.28 % | -6.64 % | -44.68 % |
| 2004 | 23.6 % | 3.8 % | -0.07 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 23.6 % | 3.8 % | -0.07 % |
| 2005 | 17.28 % | -6.64 % | -44.68 % |
| 2006 | 54.33 % | 38.16 % | 17.69 % |
| 2007 | 61.81 % | 38.58 % | 22.81 % |
| 2008 | 61.81 % | -45.26 % | -96.58 % |
| 2009 | 52.06 % | -97.37 % | -306.61 % |
| 2010 | 62.11 % | -94.14 % | -241.15 % |
| 2011 | 67.19 % | -135.61 % | -180.53 % |
| 2012 | 79.59 % | -74.67 % | -83.19 % |
| 2013 | 80.02 % | -107.7 % | -356.82 % |
| 2014 | 83.52 % | -49.45 % | -46.23 % |
| 2015 | 83.29 % | -46.78 % | -48.47 % |
| 2016 | 84.56 % | -38.04 % | -38.04 % |
| 2017 | 85.4 % | -51 % | -178.5 % |
| 2018 | 86.95 % | -87.72 % | -102.45 % |
| 2019 | 86.66 % | -28.23 % | 1.17 % |
| 2020 | 86.74 % | -18.62 % | -34.16 % |
| 2021 | 78.38 % | -0.6 % | -5.54 % |
| 2022 | 76.06 % | 10.27 % | 8.75 % |
| 2023 | 81.04 % | 15.67 % | 14.62 % |
Uni-Bio Science Group Aktienanalyse
What does Uni-Bio Science Group do?
Uni-Bio Science Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Uni-Bio Science Group's Profit Margins
The profit margins of Uni-Bio Science Group represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Uni-Bio Science Group's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Uni-Bio Science Group's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Uni-Bio Science Group's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Uni-Bio Science Group’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Uni-Bio Science Group Stock
How has the profit developed compared to last year?
The profit has increased by 84.04% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Uni-Bio Science Group publish its earnings?
Uni-Bio Science Group publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Uni-Bio Science Group?
The profits of Uni-Bio Science Group are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Uni-Bio Science Group?
You can learn more about the earnings of Uni-Bio Science Group by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Uni-Bio Science Group pay?
Over the past 12 months, Uni-Bio Science Group paid a dividend of 0.02 HKD . This corresponds to a dividend yield of about 24.15 %. For the coming 12 months, Uni-Bio Science Group is expected to pay a dividend of 0 HKD.
What is the dividend yield of Uni-Bio Science Group?
The current dividend yield of Uni-Bio Science Group is 24.15 %.
When does Uni-Bio Science Group pay dividends?
Uni-Bio Science Group pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Uni-Bio Science Group?
Uni-Bio Science Group paid dividends every year for the past 0 years.
What is the dividend of Uni-Bio Science Group?
For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Uni-Bio Science Group located?
Uni-Bio Science Group is assigned to the 'Health' sector.
Wann musste ich die Aktien von Uni-Bio Science Group kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Uni-Bio Science Group from 8/31/2007 amounting to 0.002 HKD, you needed to have the stock in your portfolio before the ex-date on 8/22/2007.
When did Uni-Bio Science Group pay the last dividend?
The last dividend was paid out on 8/31/2007.
What was the dividend of Uni-Bio Science Group in the year 2023?
In the year 2023, Uni-Bio Science Group distributed 0 HKD as dividends.
In which currency does Uni-Bio Science Group pay out the dividend?
The dividends of Uni-Bio Science Group are distributed in HKD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Uni-Bio Science Group
Our stock analysis for Uni-Bio Science Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Uni-Bio Science Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Uni-Bio Science Group Revenue
- Uni-Bio Science Group Net Income
- Uni-Bio Science Group P/E
- Uni-Bio Science Group P/S
- Uni-Bio Science Group EBIT
- Uni-Bio Science Group Dividend
- Uni-Bio Science Group Stocks
- Uni-Bio Science Group Market capitalization
- Uni-Bio Science Group Debt
- Uni-Bio Science Group Liabilities
- Uni-Bio Science Group Equity
- Uni-Bio Science Group AAQS
- Uni-Bio Science Group Employees
- Uni-Bio Science Group ROE
- Uni-Bio Science Group ROA
- Uni-Bio Science Group ROCE